- Segmentation decides who receives what: the endocrinologist gets the diabetes data, the specialist gets the deeper version. It answers who, not what happens once she opens it.
- Two community cardiologists on the same distribution list can still want two different things from the very same publication.
- One approved publication becomes a set of routes: mechanism, outcomes, patient fit. She steers, and every route still traces back to one approved core.
Segmentation gets a physician the right publication. It rarely gets her the right moment inside it. Here's what we found, and what it means for how you build your next story.
01What segmentation actually does
Segmentation decides who receives what: the endocrinologist gets the diabetes data, the specialist gets the deeper version. Here's the part that doesn’t get talked about enough: segmentation answers who should get this. It doesn’t answer what happens once she opens it.
A Beginner’s Guide to Pharma Market Segmentation, told as a story a physician can finish.
02Where the model runs out of road
Two community cardiologists on the same distribution list can still want two different things. Segmentation put the same document in front of both, because segmentation stops at specialty.
“Segmentation answers who should get this. It doesn't answer what happens once she opens it.”
03A publication that keeps segmenting after it's opened
One approved publication becomes a set of routes: mechanism, outcomes, patient fit. She steers. We don’t track what she clicks. Every route she could choose still traces back to one approved core, so one MLR review covers all of it.
04Where this fits in your current process
Bring us the publication and the therapeutic-area context you already have, we handle the mapping and the build. Nothing about your targeting changes.
